Abstract
Aim To investigate the effects of bone morphogenetic proteins (BMPs) 2, 4, and 7 on proliferation and osteogenic differentiation in human periodontal ligament stem cells (PDLSCs). Methods PDLSCs were isolated by an immunomagnetic method. Expression of cell surface antigens CD146, CD44, and CD34, and pluripotency (osteogenic and adipogenic) were measured. Cultured PDLSCs were treated, in dose- and time-dependent experiments, with single BMPs, with 1:1 combinations, and with a mix of all three BMPs (1:3 each). For dose-dependent experiments, PDLSCs were incubated for 12 d with media containing BMPs at 0, 10, 25, 50, and 100 ng/ml. For time-dependent experiments, PDLSCs were treated with media containing 50 ng/ml BMPs for 0, 3, 6, 12, and 24 d. Cell growth and alkaline phosphatase activities were measured by MTT and an enzyme kit. Immunohistochemistry and western blotting were used to detect osteogenic differentiation-related proteins, i.e., osteocalcin, bone sialoprotein, collagen type I, and collagen type III. Results PDLSCs displayed CD146 (93%) and CD44 (91.2%) positive expression; CD34 (1.8%) showed negative expression. All cells exhibited osteogenic and adipogenic potential. The proliferation and alkaline phosphatase activities of PDLSCs treated with the aforesaid single and combined BMPs increased in a dose- and time-dependent manner; proliferation and alkaline phosphatase activity were greater with the BMP combinations. Compared with the control group, the levels of osteogenic differentiation-related proteins increased markedly in PDLSCs treated with 50 ng/ml BMPs for 12 d, whereas no significant differences were observed between the different BMP treatments. Conclusion BMP-2, -4, and -7, singly and in combination, promoted development and osteogenic differentiation of PDLSCs, and both cellular outcomes were more pronounced with BMP combinations.